跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMGLIDIA 6 mg/ml SUSPENSION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMGLIDIA 6 mg/ml SUSPENSION ORAL
Approved
STANDARD
AMGLIDIA 6 mg/ml SUSPENSION ORAL
Ammtek
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 14, 2021
Approval ID
fee47533b475119b
Company
Ammtek
Type
Standard
Approval Details
Approval Id
fee47533b475119b
Drug Cima Aemps Name
AMGLIDIA 6 mg/ml SUSPENSION ORAL
Register Number
1181279003
Holder Company Name
Ammtek
Marketing Company Name
Bioprojet Pharma
Holder Company Detail Path
/organization/ammtek-ltd
Marketing Company Detail Path
/organization/bioprojet-pharma
Authorization Date
2021-01-14
Dosage Form
SUSPENSIÓN ORAL
Dose
6 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Ammtek
Company Detail Path
/organization/ammtek-ltd
Company Information
Pharmaceutical Company Name
Ammtek Ltd.
Active Ingredients
GLIBENCLAMIDA
180 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 14, 2021
Approval ID
fee47533b475119b
Type
Standard
Back to CIMA-AEMPS Approvals